Cytarabine and Hypercapnia - a phase IV clinical study of FDA data

Summary:

Hypercapnia is reported as a side effect among people who take Cytarabine (cytarabine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Hypercapnia when taking Cytarabine. It is created by eHealthMe based on reports of 65,319 people who have side effects when taking Cytarabine from the FDA, and is updated regularly.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.

What is Hypercapnia?

Hypercapnia (too much smoke) is found to be associated with 462 drugs and 654 conditions by eHealthMe. Check the latest studies of Hypercapnia.

On Aug, 05, 2026

65,319 people reported to have side effects when taking Cytarabine.
Among them, 22 people (0.03%) have Hypercapnia.

Among these 22 people:

How long have people been on Cytarabine when they have Hypercapnia? *

What is the gender of people who have Hypercapnia when taking Cytarabine? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Hypercapnia when taking Cytarabine? *

What are other drugs people take besides Cytarabine? *

What are other side effects people have besides Hypercapnia? *

Hypotension (abnormally low blood pressure): 8 people, 36.36%
Thrombocytopenia (decrease of platelets in blood): 8 people, 36.36%
Fever: 8 people, 36.36%
Cardiac Arrest: 7 people, 31.82%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 6 people, 27.27%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 22.73%
Eyes/pupils Different Size: 5 people, 22.73%
Pneumonia: 5 people, 22.73%
General Physical Health Deterioration (weak health status): 4 people, 18.18%
Blood Culture Positive: 4 people, 18.18%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 27.27%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 18.18%
Pulmonary Haemorrhage (acute bleeding from the lung): 2 people, 9.09%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 2 people, 9.09%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and have Hypercapnia?

- Check whether Hypercapnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cytarabine:

Cytarabine (65,358 reports)

Hypercapnia treatments and more:

Hypercapnia (3,855 reports)

Browse all side effects of Cytarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercapnia:

Hypercapnia (462 drugs)

Browse all the conditions that are associated with Hypercapnia:

Hypercapnia (654 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.